Metastatic Renal Cell Carcinoma (mRCC)

Explore clinical trials studying Metastatic Renal Cell Carcinoma (mRCC). Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Renal Cell Carcinoma (mRCC) trial results

Recruiting

NCT05287464

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ospedale di Macerata, UOC Oncologia Province of Macerata, Macerata, Italy

Recruiting

NCT07175480

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China Nanjing, Jiangsu, China

Completed

NCT02184416

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Landeskrankenhaus Bregenz Bregenz, Austria

AKh Linz Linz, Austria

Krankenhaus der Barmherzigen Schwestern Linz Abteilung fuer Urologie Linz, Austria

Krankenhaus Oberwart Oberwart, Austria

View all 110 locations

Completed

NCT04175262

Completed

NCT01514448

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Novartis Investigative Site Chemnitz, Germany

Novartis Investigative Site Dresden, Germany

Novartis Investigative Site Hanover, Germany

Novartis Investigative Site Hof, Germany

View all 13 locations

Completed

NCT01390519

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Novartis Investigative Site Kristiansand, Norway

Novartis Investigative Site Tromsø, Norway

Novartis Investigative Site Trondheim, Norway